HANALL BIOPHARMA CO.,LTD
Biopharmaceutical firm focused on immunology, ophthalmology, and immuno-oncology.
009420 | KO
Overview
Corporate Details
- ISIN(s):
- KR7009420001
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 대덕구 상서당1길 43, 대전광역시
- Website:
- http://www.hanallbiopharma.com/
- Sector:
- Manufacturing
Description
HanAll Biopharma is a global biopharmaceutical company focused on developing innovative, first-in-class therapies for patients with unmet medical needs. The company's research and development efforts are centered on immunology, ophthalmology, and immuno-oncology, with a specialization in antibody-based therapeutics. Its pipeline includes novel treatments for autoimmune diseases and dry eye disease. The company's mission is to pioneer cutting-edge medicines that address incurable and immune-associated conditions. Alongside its innovative pipeline, HanAll Biopharma also operates a portfolio of pharmaceutical products in therapeutic areas including endocrine, circulatory, and urologic diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-14 00:00 |
분기보고서 (2022.09)
|
Korean | 1.2 MB | ||
| 2022-10-26 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 14.0 KB | ||
| 2022-09-19 00:00 |
투자판단관련주요경영사항(자가면역질환 치료 항체신약 HL161의 일본 중증근무력증 임상 3상을 위한 시험계획서 승인)
|
Korean | 11.0 KB | ||
| 2022-08-19 00:00 |
투자판단관련주요경영사항
|
Korean | 10.4 KB | ||
| 2022-08-16 00:00 |
[기재정정]사업보고서 (2021.12)
|
Korean | 1.6 MB | ||
| 2022-08-16 00:00 |
반기보고서 (2022.06)
|
Korean | 1.2 MB | ||
| 2022-07-27 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 14.1 KB | ||
| 2022-06-24 00:00 |
자기주식처분결과보고서
|
Korean | 15.2 KB | ||
| 2022-06-24 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2022-06-24 00:00 |
최대주주등소유주식변동신고서
|
Korean | 25.1 KB | ||
| 2022-06-22 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 25.5 KB | ||
| 2022-06-15 00:00 |
자기주식취득결과보고서
|
Korean | 36.8 KB | ||
| 2022-05-16 00:00 |
분기보고서 (2022.03)
|
Korean | 1.5 MB | ||
| 2022-04-28 00:00 |
기업설명회(IR)개최(안내공시)
|
Korean | 6.0 KB | ||
| 2022-04-27 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 14.0 KB |
Automate Your Workflow. Get a real-time feed of all HANALL BIOPHARMA CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HANALL BIOPHARMA CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HANALL BIOPHARMA CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
